Cargando…

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer

INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Saad, Samer, Richardsen, Elin, Kilvaer, Thomas K., Donnem, Tom, Andersen, Sigve, Khanehkenari, Mehrdad, Bremnes, Roy M., Busund, Lill-Tove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526580/
https://www.ncbi.nlm.nih.gov/pubmed/28742836
http://dx.doi.org/10.1371/journal.pone.0181527
_version_ 1783252833140736000
author Al-Saad, Samer
Richardsen, Elin
Kilvaer, Thomas K.
Donnem, Tom
Andersen, Sigve
Khanehkenari, Mehrdad
Bremnes, Roy M.
Busund, Lill-Tove
author_facet Al-Saad, Samer
Richardsen, Elin
Kilvaer, Thomas K.
Donnem, Tom
Andersen, Sigve
Khanehkenari, Mehrdad
Bremnes, Roy M.
Busund, Lill-Tove
author_sort Al-Saad, Samer
collection PubMed
description INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two most frequent occurring EGFR gene mutations was also investigated. MATERIALS AND METHODS: Stage I to IIIA tumors from 326 patients with NSCLC were immunohistochemically tested for protein expression of MET and IGF-1. Their cytoplasmic expression was compared with the gene copy number of the MET and IGF1Rgenes by SISH in paraffin-embedded, formalin-fixed material. Correlations were made with the immunohistochemical expression of two frequent EGFR mutations and clinicopathological variables. Univariate and multivariate survival analyses was used to evaluate the prognostic efficacy of the tested markers. RESULTS: In univariate analyses, high cytoplasmic MET expression showed a significant negative prognostic effect in adenocarcinoma patients (p = 0.026). MET gene to chromosome 7 ratio was a significant positive prognostic marker (p = 0.005), probably only due to the highly negative prognostic significance of chromosome 7 polysomy (p = 0.002). High IGF1R gene copy number was a negative prognostic marker for all NSCLC patients (p = 0.037). In the multivariate analysis, polysomy of chromosome 7 in tumor cells correlated significantly and independently with a poor prognosis (p = 0.011). In patients with adenocarcinoma, a high cytoplasmic MET expression was an independent negative prognostic marker (p = 0.013). In males a high IGF1R gene copy number to chromosome 15 count ratio was significantly and independently correlated to a poor prognosis (p = 0.018). CONCLUSION: MET protein expression provides superior prognostic information compared with SISH. Polysomy of chromosome 7 is an independent negative prognostic factor in NSCLC patients. This finding has an important implication while examining genes located on chromosome 7 by means of SISH. High IGF1R gene copy number to chromosome 15 count ratio is an independent predictor of inferior survival in male patients with primary NSCLC.
format Online
Article
Text
id pubmed-5526580
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55265802017-08-07 The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer Al-Saad, Samer Richardsen, Elin Kilvaer, Thomas K. Donnem, Tom Andersen, Sigve Khanehkenari, Mehrdad Bremnes, Roy M. Busund, Lill-Tove PLoS One Research Article INTRODUCTION: To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two most frequent occurring EGFR gene mutations was also investigated. MATERIALS AND METHODS: Stage I to IIIA tumors from 326 patients with NSCLC were immunohistochemically tested for protein expression of MET and IGF-1. Their cytoplasmic expression was compared with the gene copy number of the MET and IGF1Rgenes by SISH in paraffin-embedded, formalin-fixed material. Correlations were made with the immunohistochemical expression of two frequent EGFR mutations and clinicopathological variables. Univariate and multivariate survival analyses was used to evaluate the prognostic efficacy of the tested markers. RESULTS: In univariate analyses, high cytoplasmic MET expression showed a significant negative prognostic effect in adenocarcinoma patients (p = 0.026). MET gene to chromosome 7 ratio was a significant positive prognostic marker (p = 0.005), probably only due to the highly negative prognostic significance of chromosome 7 polysomy (p = 0.002). High IGF1R gene copy number was a negative prognostic marker for all NSCLC patients (p = 0.037). In the multivariate analysis, polysomy of chromosome 7 in tumor cells correlated significantly and independently with a poor prognosis (p = 0.011). In patients with adenocarcinoma, a high cytoplasmic MET expression was an independent negative prognostic marker (p = 0.013). In males a high IGF1R gene copy number to chromosome 15 count ratio was significantly and independently correlated to a poor prognosis (p = 0.018). CONCLUSION: MET protein expression provides superior prognostic information compared with SISH. Polysomy of chromosome 7 is an independent negative prognostic factor in NSCLC patients. This finding has an important implication while examining genes located on chromosome 7 by means of SISH. High IGF1R gene copy number to chromosome 15 count ratio is an independent predictor of inferior survival in male patients with primary NSCLC. Public Library of Science 2017-07-25 /pmc/articles/PMC5526580/ /pubmed/28742836 http://dx.doi.org/10.1371/journal.pone.0181527 Text en © 2017 Al-Saad et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Al-Saad, Samer
Richardsen, Elin
Kilvaer, Thomas K.
Donnem, Tom
Andersen, Sigve
Khanehkenari, Mehrdad
Bremnes, Roy M.
Busund, Lill-Tove
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title_full The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title_fullStr The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title_full_unstemmed The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title_short The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
title_sort impact of met, igf-1, igf1r expression and egfr mutations on survival of patients with non-small-cell lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526580/
https://www.ncbi.nlm.nih.gov/pubmed/28742836
http://dx.doi.org/10.1371/journal.pone.0181527
work_keys_str_mv AT alsaadsamer theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT richardsenelin theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT kilvaerthomask theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT donnemtom theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT andersensigve theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT khanehkenarimehrdad theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT bremnesroym theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT busundlilltove theimpactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT alsaadsamer impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT richardsenelin impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT kilvaerthomask impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT donnemtom impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT andersensigve impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT khanehkenarimehrdad impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT bremnesroym impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer
AT busundlilltove impactofmetigf1igf1rexpressionandegfrmutationsonsurvivalofpatientswithnonsmallcelllungcancer